Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2010 1
2012 1
2013 1
2014 3
2015 6
2016 1
2017 3
2018 6
2019 7
2020 10
2021 20
2022 14
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
Prospective International Randomized Phase II Study of Low-Dose Abiraterone With Food Versus Standard Dose Abiraterone In Castration-Resistant Prostate Cancer.
Szmulewitz RZ, Peer CJ, Ibraheem A, Martinez E, Kozloff MF, Carthon B, Harvey RD, Fishkin P, Yong WP, Chiong E, Nabhan C, Karrison T, Figg WD, Stadler WM, Ratain MJ. Szmulewitz RZ, et al. Among authors: carthon b. J Clin Oncol. 2018 May 10;36(14):1389-1395. doi: 10.1200/JCO.2017.76.4381. Epub 2018 Mar 28. J Clin Oncol. 2018. PMID: 29590007 Free PMC article. Clinical Trial.
Blood-Based Next-Generation Sequencing in Adrenocortical Carcinoma.
Nazha B, Zhuang TZ, Dada HI, Drusbosky LM, Brown JT, Ravindranathan D, Carthon BC, Kucuk O, Goldman J, Master VA, Bilen MA. Nazha B, et al. Among authors: carthon bc. Oncologist. 2022 Jun 8;27(6):462-468. doi: 10.1093/oncolo/oyac061. Oncologist. 2022. PMID: 35462410 Free PMC article.
Update on systemic therapy for advance prostate cancer.
Carthon B, Rossi PJ. Carthon B, et al. Curr Probl Cancer. 2015 Jan-Feb;39(1):52-62. doi: 10.1016/j.currproblcancer.2014.11.009. Epub 2014 Nov 25. Curr Probl Cancer. 2015. PMID: 25637932 Review. No abstract available.
Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: results from a phase I/II open-label, multicenter study.
Zucali PA, Lin CC, Carthon BC, Bauer TM, Tucci M, Italiano A, Iacovelli R, Su WC, Massard C, Saleh M, Daniele G, Greystoke A, Gutierrez M, Pant S, Shen YC, Perrino M, Meng R, Abbadessa G, Lee H, Dong Y, Chiron M, Wang R, Loumagne L, Lépine L, de Bono J. Zucali PA, et al. Among authors: carthon bc. J Immunother Cancer. 2022 Jan;10(1):e003697. doi: 10.1136/jitc-2021-003697. J Immunother Cancer. 2022. PMID: 35058326 Free PMC article. Clinical Trial.
The Genomic Landscape of Urothelial Carcinoma with High and Low ERBB2 Expression.
Hadadi A, Krause HB, Elliott A, Brown JT, Nazha B, Harik LR, Carthon BC, Miron B, Nabhan C, Barata PC, Saleh M, Yang Y, McKay RR, Bilen MA. Hadadi A, et al. Among authors: carthon bc. Cancers (Basel). 2023 Dec 6;15(24):5721. doi: 10.3390/cancers15245721. Cancers (Basel). 2023. PMID: 38136267 Free PMC article.
70 results